“STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS”. Research Focus International Scientific Journal 2, no. 1 (February 5, 2023): 11–19. Accessed September 12, 2026. https://refocus.uz/index.php/rf/article/view/2819.